| NOVONESIS A/S NAM. B DK 2 |
| Dänemark |
| Chemie |
| DK0060336014 / A1JP9Y |
| NZM2 (Frankfurt) |
| FRA:NZM2, ETR:NZM2, NZM2:GR |
| - |
| https://www.novonesis.com.. |
|
Novonesis (Novozymes) B is the Class B share of Novonesis A/S, a leading biotechnology company headquartered in Lyngby, Denmark. Formed in 2024 through the merger of Novozymes and Chr. Hansen, it holds a dominant near-50% market share in industrial e..
>Volltext.. |
| 24073.22 Mio. EUR |
| 26775.75 Mio. EUR |
| 4217.65 Mio. EUR |
| 1483.92 Mio. EUR |
| 592 Mio. EUR |
| 1.27 EUR |
| 3051.16 Mio. EUR |
| 279.49 Mio. EUR |
| 1239.15 Mio. EUR |
| 0.11 |
| 8.43% |
| 90.78% |
| 0.87 EUR |
| 1.7% |
| 1.71% |
| 20.03.26 - 0.5688413€ 21.08.25 - 0.301095€ >weitere anzeigen... |
| - |
| NOVONESIS, NOVOZYMES |
| 05.04.26 |
|
||||
|
||||
|
||||
|